Deep Health AI India Ltd (539559)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- Q2 FY27, தாக்கல் செய்யப்பட்டது 3 நவ. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 10 ஆக. 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
Deep Health AI India Ltd reported Q2 FY27 results on 3 Nov 2026: revenue ₹0.5 Cr (-86.6% year on year, +0.0% on the previous quarter), and net profit ₹0.2 Cr (-91.7% year on year); the operating margin was 44.4%.
| Q2 FY27 (₹ கோடி) | மதிப்பு | YoY Q2 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹0.5 | -86.6% | +0.0% |
| செயல்பாட்டு லாபம் | ₹0.2 | -93.8% | நஷ்டத்திலிருந்து |
| நிகர லாபம் | ₹0.2 | -91.7% | நஷ்டத்திலிருந்து |
| EPS (₹) | 0.01 | -94.4% | நஷ்டத்திலிருந்து |
| செயல்பாட்டு லாப வரம்பு | 44.4% | — | — |
- லாபம் அதன் சொந்தப் போக்கை விட -96% கீழே
- செயல்பாட்டு லாப வரம்பு 5236 bps YoY குறைந்தது
- வரிக்கு முந்தைய லாபத்தில் 41% மற்ற வருமானம் மற்றும் ஒருமுறை கிடைத்த வருமானங்களிலிருந்து வந்தது.
- லாபம் இருந்தும் FY26-இல் செயல்பாட்டுப் பணப்புழக்கம் எதிர்மறையாக இருந்தது
லாபத்தின் தரம்: வரிக்கு முந்தைய ₹0.3 கோடி லாபத்தில், ₹0.2 கோடி (59%) முக்கிய வணிகத்திலிருந்து வந்தது; மீதம் பிற வருமானம் மற்றும் ஒருமுறை வரவுகளிலிருந்து வந்தது. முக்கிய லாபம் (செயல்பாட்டு லாபத்தில் வட்டி மற்றும் தேய்மானத்தைக் கழித்தது) YoY அடிப்படையில் -94.1% மாறியுள்ளது.
அதன் சொந்தப் போக்குக்கு எதிராக: நிகர லாபம் ₹0.2 கோடியாக இருந்தது; இது, அதன் சமீபத்திய வளர்ச்சி சுட்டிக்காட்டிய ₹5.1 கோடியுடன் ஒப்பிடும்போது -95.9% ஆகும் (below trend). இது ஒரு புள்ளியியல் அடிப்படை மட்டுமே; ஆய்வாளர் மதிப்பீடு அல்ல.
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Deep Health AI India Limited (formerly Deep Diamond India Limited) informed BSE that its Board met on November 03, 2026, and approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. However, the specific financial figures and tables were omitted from the cover intimation. The meeting commenced at 03:00 PM and concluded at 07:35 PM. The trading window closure remains in effect until 48 hours post-declaration.
- Board approved Un-Audited Standalone and Consolidated Results for the quarter and half-year ended September 30, 2026
- Board meeting commenced at 03:00 P.M and concluded at 07:35 P.M on November 03, 2026
- Trading window closed from October 01, 2026, and will reopen 48 hours after declaration
- Actual P&L numbers were not attached in this specific intimation filing
Deep Health AI India Ltd has approved an addendum to its March 6, 2026 MoU with Elegant Floriculture & Agrotech (India) Ltd to acquire ~49,100 sq meters of agricultural land in Pune, Maharashtra. The total sale consideration has been increased from ₹18.00 crore to ₹19.50 crore, an 8.3% cost escalation. The company noted that ₹5.625 crore has already been paid as an advance, and the timeline to settle the balance and complete the transaction is extended by one year. The total deal size of ₹19.50 crore is massive relative to the firm's balance sheet, representing ~70% of its market capitalization (₹28 crore) and nearly 4x its TTM revenue (₹5 crore).
- Total consideration increased to ₹19,50,00,000 from the earlier ₹18,00,00,000
- Advance payment of ₹5,62,50,000 already acknowledged as paid by the company
- Timeline for balance payment and transaction completion extended by one year
- Land parcel spans approximately 49,100 square metres in Taluka Maval, Pune
Deep Health AI India Ltd's Board approved the acquisition of debt owed by Sparion Infrastructure Private Limited from Kshitij Polyline Limited for ₹10.35 Cr. The transaction will be executed via a Deed of Assignment on an 'as is where is' and 'without recourse' basis. The acquisition includes underlying security, specifically a pledge of 4,900 equity shares (49% stake) of Sparion Infrastructure. Relative to Deep Health AI's TTM revenue of ₹5 Cr and net worth of ₹52 Cr, this assignment represents a significant capital commitment of over 200% of annual revenue.
- Assignment consideration stands at ₹10,35,35,520/-
- Debt is acquired from Assignor M/s. Kshitij Polyline Limited owed by Sparion Infrastructure Private Limited
- Underlying security includes pledge of 4,900 equity shares representing 49% equity shareholding of Sparion Infrastructure Private Limited
- Assignment terms are on an 'as is where is', 'as is what is', and 'without recourse' basis
Deep Health AI India reported a standalone net loss of Rs 1.90 crore for the quarter ended June 30, 2026, a sharp decline from a profit of Rs 0.09 crore in the year-ago period. While revenue from operations grew 200% YoY to Rs 45 lakhs, it was entirely driven by the pharmaceutical segment as the jewellery business reported zero revenue. The bottom line was weighed down by a significant spike in 'Other Expenses' totaling Rs 2.46 crore, which exceeded total income by over 4x. Despite the operational loss, a high Other Comprehensive Income of Rs 6.89 crore led to a Total Comprehensive Income of Rs 4.99 crore.
- Revenue from operations increased to Rs 45.00 lakhs from Rs 15.00 lakhs in the same quarter last year.
- Net loss for the quarter stood at Rs 189.90 lakhs compared to a profit of Rs 9.33 lakhs YoY.
- Other expenses surged to Rs 245.88 lakhs, significantly impacting the operating margins.
- Pharmaceutical segment contributed 100% of the Rs 45.00 lakhs revenue from operations, with zero revenue from Jewellery.
- Total Comprehensive Income reached Rs 499.12 lakhs, bolstered by a Rs 689.02 lakh gain in Other Comprehensive Income.
Deep Health AI India Ltd (formerly Deep Diamond India Limited) has scheduled a board meeting for August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. This follows a volatile FY26 where the company reported a TTM revenue of Rs 4 Cr and a significant net loss of Rs 4.51 Cr in the most recent March 2026 quarter. The company is a micro-cap with a market capitalization of Rs 25 Cr and negligible promoter holding at 0.03%. The trading window for insiders has been closed since July 01, 2026.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
- Trading window closed from July 01, 2026, until 48 hours after the results declaration.
- Company reported a net loss of Rs 4.51 Cr in the previous quarter ended March 2026.
- Promoter holding remains critically low at 0.03% as of June 2026.
Deep Health AI India Ltd (formerly Deep Diamond India Ltd) has received shareholder approval for the appointment of two Non-Executive Independent Directors. Mr. Bhupesh Swami, who has 20 years of experience in logistics and export-import, has been appointed for a 2-year term effective July 02, 2026. Mrs. Shashi Kala Dhabriya has been appointed for a 5-year term effective March 20, 2026. These appointments occur within a micro-cap company (Rs 26 Cr market cap) characterized by an exceptionally low promoter holding of 0.03%.
- Appointment of Mr. Bhupesh Swami for a 2-year term ending July 01, 2028
- Appointment of Mrs. Shashi Kala Dhabriya for a 5-year term ending March 19, 2031
- Shareholder approval obtained at the Extra-Ordinary General Meeting held on July 30, 2026
- Company maintains a very small scale with TTM revenue of only Rs 4 Cr
- Promoter holding remains negligible at 0.03% as of June 2026
Deep Health AI India Ltd (formerly Deep Diamond India Ltd) has disclosed a delayed update regarding the acquisition of 49,100 sq. mtr. of land in Pune, Maharashtra. The company has paid an aggregate advance of Rs 2.85 crore in 10 tranches to Elegant Floriculture & Agrotech (India) Limited, with the final payment made on June 06, 2026. This acquisition marks a strategic shift toward wellness and agro-tourism, including a naturopathy centre and medicinal plant cultivation. The disclosure was delayed by over four months from the initial MoU date of March 06, 2026, which the company attributed to an administrative oversight.
- Advance payment of Rs 2,85,00,000 (Rs 2.85 Cr) made for land acquisition
- Land area totals 49,100 sq. mtr. located in Maval, Pune, Maharashtra
- MoU signed on March 06, 2026, with the final advance tranche paid on June 06, 2026
- Project focus includes a naturopathy centre and cultivation of medicinal plant species
- Disclosure made on July 13, 2026, following a delay from the original March 2026 MoU date
Deep Health AI India Ltd (formerly Deep Diamond India Limited) has submitted a revised Auditor's Report for the financial year ended March 31, 2026. The revision addresses an inadvertent omission in the original report submitted on May 29, 2026, which failed to list the specific entities included in the consolidated financial statements. The company has explicitly stated that this correction has no impact on the reported financial figures or the audit opinion. The standalone and consolidated results remain identical to those previously disclosed.
- Original financial results for FY26 were approved by the Board on May 29, 2026
- Revised Auditor's Report submitted on July 13, 2026, to include names of consolidated entities
- Company confirms 0% change in the Audited Standalone and Consolidated Financial Results
- The omission was described as purely inadvertent with no impact on the audit opinion
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
